Do CDK4/6 inhibitors have potential as targeted therapeutics for squamous cell cancers? - Wikidata - awgldk - TriplyDB

Do CDK4/6 inhibitors have potential as targeted therapeutics for squamous cell cancers?

Do CDK4/6 inhibitors have potential as targeted therapeutics for squamous cell cancers?

http://www.wikidata.org/entity/Q39044576

about

Novel DNA targeted therapies for head and neck cancers: clinical potential and biomarkers.Circ-ZEB1.33 promotes the proliferation of human HCC by sponging miR-200a-3p and upregulating CDK6

P2860

Q45790068-B40A7143-365D-42C0-A301-9A25D577C5F2 Q58786576-4D7C08F2-B635-4A77-9D5F-E0394CBFC69B

P2860

Do CDK4/6 inhibitors have potential as targeted therapeutics for squamous cell cancers?

http://www.wikidata.org/entity/Q39044576

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Do CDK4/6 inhibitors have potential as targeted therapeutics for squamous cell cancers?

@en

Do CDK4/6 inhibitors have potential as targeted therapeutics for squamous cell cancers?

@nl

type

label

Do CDK4/6 inhibitors have potential as targeted therapeutics for squamous cell cancers?

@en

Do CDK4/6 inhibitors have potential as targeted therapeutics for squamous cell cancers?

@nl

prefLabel

Do CDK4/6 inhibitors have potential as targeted therapeutics for squamous cell cancers?

@en

Do CDK4/6 inhibitors have potential as targeted therapeutics for squamous cell cancers?

@nl

P1433

Q39044576-D232B6C6-158B-404F-99BD-9552076C3C43

P1476

Q39044576-454CAA98-96B9-494E-90B4-3FCED22517B0

P2093

Q39044576-00FB258E-2639-4F6C-AD2B-CCA7177FE9F7

Q39044576-38011FDE-4588-426E-996A-1574CF345E19

P2860

Q39044576-04061C71-4260-44BC-9234-33109207BE4B

Q39044576-075FC97F-19C7-448D-AED8-2C28AA5A9C26

Q39044576-12BE50CE-FD6D-4469-8E10-CA3826628792

Q39044576-136E0EF3-160B-4939-B6F9-52D93F5273F4

Q39044576-13E6E750-43DD-4A2B-853D-03F1BA7021A6

Q39044576-16686456-15E1-48C9-9A64-5D155A505192

Q39044576-19DE6353-89DF-4E5A-8043-41F1C1BE49F7

Q39044576-1D692E40-B24A-42BE-8176-6B38D4C0ED34

Q39044576-1FCD58AF-A424-4811-B733-F0AED220DF8E

Q39044576-2019F5AD-D287-4F8D-A5C4-3872ADB5FF5C

P304

Q39044576-BA58FC6D-B6CB-4E1D-9530-11809BD511DC

P31

Q39044576-CB1A12CF-717D-4777-919C-E9D49376A7DA

P356

Q39044576-1EA2E89C-0B13-48ED-90DC-D9C01E398F80

P407

Q39044576-3A567FEF-47B7-43FA-8F9A-1803EF5314E4

P433

Q39044576-5038B301-9907-4B0C-BEC1-5FBEE7757ABB

P478

Q39044576-17D02794-A95C-46AC-83A5-114577A3DD23

P577

Q39044576-55FB7B11-BC59-4DA1-9005-0194B36D9ECB

P698

Q39044576-324ACB3A-49C4-461D-A953-E520D545937B

P356

13543784.2017.1274731

P1433

Expert Opinion on Investigational Drugs

P1476

Do CDK4/6 inhibitors have potential as targeted therapeutics for squamous cell cancers?

@en

P2093

Faye M Johnson

http://www.w3.org/2001/XMLSchema#string

Nene N Kalu

http://www.w3.org/2001/XMLSchema#string

P2860

A first-in-human, phase 1, dose-escalation study of dinaciclib, a novel cyclin-dependent kinase inhibitor, administered weekly in subjects with advanced malignancies

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

Targeting CDK4/6 in patients with cancer

EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection

Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer.

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma.

Mutational landscape of aggressive cutaneous squamous cell carcinoma

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.

Targeting CDK4 and CDK6: From Discovery to Therapy

Comprehensive genomic characterization of head and neck squamous cell carcinomas

P304

207-217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543784.2017.1274731

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28042706

http://www.w3.org/2001/XMLSchema#string